Shilpa Medicare Ltd Board Meeting Scheduled to Approve Q2 Unaudited Financial Results
Shilpa Medicare Limited has announced a forthcoming meeting of its Board of Directors. The meeting is scheduled for Wednesday, 05 August 2026. The primary agenda item for the board is to consider and approve the unaudited financial results of the company for the quarter ending 30 June, 2026.In addition to the board meeting announcement, Shilpa Medicare Limited provided an update regarding its insider trading policy. The company confirmed that the Trading Window has been closed effective from 01 July 2026. This restricted trading status will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ended 30 June, 2026.
SHILPAMED Stock Price Movement
As of 11:56 AM, shares of Shilpa Medicare Limited are shedding value, slipping 0.45% in live trading with the stock currently priced at ₹602.5. The equity is navigating significant intraday volatility, having traded within a range between a low of ₹600.5 and a high of ₹616.3.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.